A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients.
Sarah Anne BirdCharlotte PawlynSusanna NallamilliPriya SriskandarajahMartin F KaiserKwee L YongRakesh PopatNeil RabinKevin D BoydPublished in: British journal of haematology (2020)